FY/Q4 2017 Investor Conference Call

Wednesday, February 28, 2018
Start at approx. 2:00 p.m. CET (1:00 p.m. UTC)

Investor News February 28, 2018

Fiscal 2017:

Bayer: business at prior-year level - on track with strategy

Group sales increased by 1.5 percent (Fx & portfolio adj.) to 35.015 billion euros / Another record year for Pharmaceuticals / Weak business development at Consumer Health / Crop Science business down against prior year due to situation in Brazil - measures taking effect / EBITDA before special items level year on year at 9.288 billion euros / Net income raised by 61.9 percent to 7.336 billion euros / Core earnings per share increased by 1.0 percent to 6.74 euros / Covestro deconsolidated - additional cash inflows of 4.7 billion euros / Monsanto acquisition expected to close in second quarter of 2018 / Group outlook for 2018: increase in sales (Fx & portfolio adj.), EBITDA before special items and core earnings per share at prior-year level due to currency effects


Werner Baumann
CEO of Bayer AG

Audio recording of the investor conference call


Audio file

You can also play the audio recording on your mobile device.


Johannes Dietsch
CFO of Bayer AG

Presentation charts

Annual Report 2017

Q4 2017 Analyst and Investor Briefing


FY/Q4 2017 All in One Package for Investors and Analysts